On February 20th, according to reports from South Korean media, KT&G, PMI, and BAT have all recently released new heat-not-burn products, along with exclusive pods that are being sold at higher prices than before. This trend started at the end of last year.
As it is known, the new products launched by these three companies are not compatible with their existing pods or pods from third-party companies.
BAT has launched four exclusive pods under the brand name Neo, coinciding with the release of Glo Hyper X2. However, the length and thickness of these pods are different from their previous models, and therefore cannot be used with existing Glow Pro Slim devices.
PMI Korea's new product, IQOS ILUMA, is not compatible with the previous IQOS Duo 3's proprietary podHits. ILUMA requires the use of an exclusive podTeria.
Meanwhile, both BAT and PMI have raised the price of their pods from 4,500 Korean won (approximately 23.8 yuan) to 4,800 Korean won (approximately 25.4 yuan) during the launch of their new products.
When it comes to KT&G's existing product, Lil Hybrid, the price for a pod is 4,500 Korean won (approximately 23.8 yuan) plus 500 won for the pod, which brings the average cost to 5,000 Korean won (approximately 26.5 yuan) per unit. This new product raises the price of a single cigarette to 4,800 Korean won (approximately 25.4 yuan) without the pod.
Reference/Bibliography:
Cigarette prices increasing, causing ripples in the alcohol industry
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
